COR-ART: A multicenter, randomized, double-blind, placebo-controlled dose-ranging study to evaluate single oral doses of vanoxerine for conversion of recent-onset atrial fibrillation or flutter to normal sinus rhythm

Article ID	Journal	Published Year	Pages	File Type
5960125	Heart Rhythm	2015	8 Pages	PDF

Abstract

Oral vanoxerine converted AF/AFL to SR at a high rate, was well tolerated, and caused no ventricular proarrhythmia.

Keywords

AFL QTcF Arrhythmia ECG electrocardiogram Ventricular tachycardia DC, Direct current Sinus rhythm Atrial flutter Atrial fibrillation cardioversion

Related Topics

Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine

Preview

COR-ART: A multicenter, randomized, double-blind, placebo-controlled dose-ranging study to evaluate single oral doses of vanoxerine for conversion of recent-onset atrial fibrillation or flutter to normal sinus rhythm

Authors

Howard C. MD, Gregory K. MD, FHRS, Tristram D. MD, FHRS, A. John MD, FHRS, Sergey MD, Amos MD, Jason I. MD, PhD, Peter R. MD, FHRS, Albert L. MD, PhD, FHRS (Hon), Arthur M. MD, PhD,